1.Immunoreactive Scoring of Metallothionein-3 (MT-3) Expression as an Indicator of Metallic Taste Rats which are Induced by Doxorubicin and Antioxidant
Jenny Sunariani ; Lutfi Malia Rossa ; Yuliati Yuliati ; Indeswati Diyatri ; Wisnu Setyari Juliastuti ; Aqsa Sjuhada Oki1
Malaysian Journal of Medicine and Health Sciences 2020;16(Supp 4, July):42-46
Introduction: Cancer is one of the leading causes of deathworldwide. Chemotherapy like as doxorubicin is the most
common treatment procedure given to cancer patients. Doxorubicin is a cytotoxic drug that triggers the production
of Reactive Oxygen Species (ROS) affect to body cells including taste bud cells to induced the expression of Metallothionein 3 (MT-3), eventually cause cell damage that leads to a metallic taste. Antioxidant therapy can be an alternative to overcome metallic taste as it counters ROS effect and lowers the expression of MT-3. The aim of this study
is to evaluate MT-3 expression in the taste bud cells of male Wistar Rats after induction of doxorubicin combined
with vitamin E and mung bean sprouts (Phaseolusradiatus L.) juice. Methods: 27 male Wistar rats weighing 250-300
g aged 3-4 months were divided into 3 groups randomly; control group, treatment group 1 (receiving doxorubicin
and vitamin E), and treatment group 2 (receiving doxorubicin and mung bean sprouts juice). After 5 days, the rats
were sacrificed, and the tongue was taken for immunohistochemistry analysis. Data were then analyzed by One
Sample Kolmogorov-Smirnov, Levene Test, and Oneway-ANOVA statistical test (p<0.05). Results: The MT-3 expression increases in the following order; control group (4.93), treatment group 2 (7.08), and treatment group 1 (9.95).
Treatment group 1 and 2 both show remarkable increases of MT-3 expression compare to control. Conclusion: The
induction of doxorubicin and antioxidant can increase the level of MT-3 expression.